Call Now! 866-464-3202
This is a custom template (Home Pages: Video Center Area - AUTO PLAY WITH MUTED SOUND) that is currently displayed on the following pages: * third column

Video Center

BB BIOTECH AG · Schaffhausen Switzerland ·(Swiss: BIO)

Company Description

Vordergasse 3
Schaffhausen
CH-82-00
Switzerland (Map)
Phone: +41-52-624-08-45
Fax: +41-52-624-60-29
Rankings
  • TecDAX
View BB BIOTECH AG Locations On A US MapThis link will open in a new window

BB BIOTECH is banking on genetics. The investment firm funds biotechnology companies across the globe. BB BIOTECH's portfolio includes large stakes in half a dozen companies such as Actelion and Biogen Idec; the company also holds smaller shares in about 15 others. The firm usually makes only limited investments (not taking more than a 10% stake) in non-public companies. When considering an investment, the firm looks for key development markers. BB BIOTECH prefers to take stakes in companies that are within two years of bringing a product to market. To read the full description, subscribe now.

Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!

Key BB BIOTECH AG Financials

Company TypePublic - Swiss: BIO

Headquarters
Fiscal Year-EndDecember
2008 Sales (mil.)$69.9
Employees16,400

BB BIOTECH AG Executives

8 executives listed for BB BIOTECH AG's Schaffhausen,  location.
TitleName & BioContact
ChairmanThomas SzucsNetwork
Vice ChairmanDavid BaltimoreNetwork
Co-ManagerDaniel KollerNetwork

Competition

Competitive Landscape for BB BIOTECH AG
Demand is driven primarily by the pace of technological innovation and the number of companies created to commercialize new technologies. The profitability of individual companies depends on successfully choosing and managing a portfolio of investments. Large companies have advantages in attracting investors, developing expertise in multiple technology markets, and funding large deals. Small companies can compete effectively by concentrating on specific market sectors or geographic areas. The average venture capital investment is about $8 million. Individual, or angel, investors, and large companies with strategic interests in early-stage companies are also sources of new venture funding. To read the full description, subscribe now.
Top BB BIOTECH AG Competitors
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!